⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7154944 | 1.00 | — | — | |
| SCHEMBL4310324 | 1.00 | — | — | |
| SCHEMBL467527 | 1.00 | — | — | |
| SCHEMBL11067254 | 1.00 | — | — | |
| SCHEMBL17984919 | 0.85 | ALDH1A1 (0.32) | — | |
| SCHEMBL17984925 | 0.85 | HIF1A (0.41) | — | |
| Iodide SCHEMBL30151177 | 0.83 | HIF1A (0.39) | — | |
| SCHEMBL11902617 | 0.81 | TSHR (0.44) | — | |
| SCHEMBL28569086 | 0.81 | — | — | |
| SCHEMBL749955 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 295 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025083657-A1 | LIPID COMPOUND AND COMPOSITION FOR TISSUE-SPECIFIC DELIVERY OF ACTIVE SUBSTANCE | 한국생명공학연구원 | 2025-04-24 | — | — | WO | claimed |
| WO-2014209507-A1 | CARDIAC GLYCOSIDE ANALOGS AND THEIR USE IN METHODS FOR INHIBITION OF VIRAL INFECTION | THE JOHNS HOPKINS UNIVERSITY (US) | 2014-12-31 | — | — | WO | claimed |
| CN-102533813-A | Biosynthetic gene cluster of amicetin and application thereof | SOUTH CHINA SEA INST OCEANOLOG | 2012-07-04 | — | — | CN | claimed |
| US-7538092-B2 | Pharmaceutically active oligosaccharide conjugates | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2009-05-26 | — | — | US | claimed |
| EP-1549350-B1 | PHARMACEUTICALLY ACTIVE OLIGOSACCHARIDE CONJUGATES | FRESENIUS KABI DE GMBH (DE) | 2008-09-24 | — | — | EP | claimed |
| US-20060100163-A1 | Pharmaceutically active oligosaccharide conjugates | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2006-05-11 | — | — | US | claimed |
| US-20050267169-A1 | Watersoluble prodrugs of propofol | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2005-12-01 | — | — | US | claimed |
| EP-1554242-A1 | WATERSOLUBLE PRODRUGS OF PROPOFOL | Fresenius Kabi Deutschland GmbH (DE) | 2005-07-20 | — | — | EP | claimed |
| EP-1549350-A1 | PHARMACEUTICALLY ACTIVE OLIGOSACCHARIDE CONJUGATES | Fresenius Kabi Deutschland GmbH (DE) | 2005-07-06 | — | — | EP | claimed |
| WO-2004033424-A1 | WATERSOLUBLE PRODRUGS OF PROPOFOL | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2004-04-22 | — | — | WO | claimed |
| WO-2004032971-A1 | PHARMACEUTICALLY ACTIVE OLIGOSACCHARIDE CONJUGATES | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2004-04-22 | — | — | WO | claimed |
| US-5593970-A | ANTITUMOR AND ANTCARCINOGENIC AGENTS; TRETMENT OF CANCEROUS BONE MARROW BEFORE REGRAFTING | BIOCHEM PHARMA INC. (CA) | 1997-01-14 | — | — | US | claimed |
| WO-1995012588-A1 | ANTINEOPLASTIC HETERONAPHTHOQUINONES | BIOCHEM PHARMA INC. (CA) | 1995-05-11 | — | — | WO | claimed |
| CN-1094402-A | Antineoplastic heteronaphthoquinones | IAF BIOCHEM INT (CA) | 1994-11-02 | — | — | CN | claimed |
| EP-0533744-A1 | HETEROCYCLIC ANTHRACYCLIONE AND ANTHRACYCLINE ANALOGS | BIOCHEM PHARMA INC. (CA) | 1993-03-31 | — | — | EP | claimed |
| CN-1058781-A | New heterocyclic anthracycline hydrocarbon homologue | IAF BIOCHEM INT (CA) | 1992-02-19 | — | — | CN | claimed |
| WO-1991019725-A2 | HETEROCYCLIC ANTHRACYCLIONE AND ANTHRACYCLINE ANALOGS | BIOCHEM PHARMA INC. (CA) | 1991-12-26 | — | — | WO | claimed |
| JP-58074694-A | — | — | None | — | — | JP | disclosed |
| US-4204038-A | FROM STREPTOMYCES | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) | 1980-05-20 | — | — | US | disclosed |
| US-4144329-A | Antitumor antibiotics MA 144-M1 and MA 144-M2 | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYUKAI (JP) | 1979-03-13 | — | — | US | disclosed |